首页> 外文期刊>Journal of Bone Oncology >Incidence of distal bone metastases in patients treated for palliative radiotherapy and associations with primary tumour types
【24h】

Incidence of distal bone metastases in patients treated for palliative radiotherapy and associations with primary tumour types

机译:姑息性放疗及与原发肿瘤类型相关联的患者远端骨转移的发生率

获取原文
获取外文期刊封面目录资料

摘要

Purpose: This study assesses the incidence of distal bone metastases in palliative radiotherapy (RT) patients. Material and methods: All courses of RT for bone metastases from 2007-2011 for patient living in British Columbia (BC) were identified in a provincial RT programme. Treated bone metastases (BoM) were categorized as distal if the BoM was located within or distal to the elbow or knee. Patients were grouped by primary tumour site as breast, lung, prostate gastrointestinal, haematological, melanoma, and other. The incidence of distal bone metastases and associations with primary tumour types were determined. Results: From 2007 to 2011, 8008 patients were treated with 16,277 courses of RT, of which 425 (3%) were courses of RT for distal BoM. The incidence of distal BoM in decreasing order by primary tumour type was melanoma (5%), haematological (3%), lung (2%), other (2%), prostate (2%), breast (1%) and gastrointestinal (1%). Distal BoM where more commonly identified in the lower extremity (87%, p<0.001). Single fraction RT was used more commonly for distal vs non-distal BoM (66% vs. 49%; p<0.001). Conclusion: The incidence of distal BoM among patients treated with palliative RT was 3% and most commonly identified in patients with melanoma and haematological malignancies.
机译:目的:本研究评估姑息性放疗(RT)患者远端骨转移的发生率。材料和方法:在省级RT计划中确定了2007-2011年间不列颠哥伦比亚省(BC)患者的所有骨转移的RT疗程。如果BoM位于肘部或膝盖内或远端,则已治疗的骨转移(BoM)归为远端。按原发肿瘤部位将患者分为乳腺,肺,前列腺胃肠道,血液学,黑色素瘤等。确定远端骨转移的发生率以及与原发肿瘤类型的关联。结果:从2007年到2011年,对8008例患者进行了16,277疗程的RT治疗,其中425(3%)是远端BoM的RT疗程。远端BoM的发生率按原发性肿瘤类型的降序排列为黑色素瘤(5%),血液学(3%),肺(2%),其他(2%),前列腺(2%),乳腺(1%)和胃肠道(1%)。远端BoM更常见于下肢(87%,p <0.001)。单分数RT更常用于远端BoM与非远端BoM(66%vs. 49%; p <0.001)。结论:姑息性放疗患者远端BoM的发生率为3%,最常见于黑色素瘤和血液系统恶性肿瘤患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号